The efficacy of transient and topical TSLP induction in delivering a lasting tumor-specific immunity in the breast highlights the potential for the use of TSLP inducers such as calcipotriol as safe and accessible agents for breast cancer immunoprevention. Here, TSLP is linked to breast carcinoma.